Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BYDUREON[1] Exenatide (Synonym: BYDUREON BCise)[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 6, 17
2Bydureon 2 mg powder and solvent for prolonged-release suspension[2] Exenatide (Synonym: BYDUREON BCise),
Manganese citrate		[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6
3EXENATIDE
(Synonym: BYDUREON BCISE)		[1] Exenatide (Synonym: BYDUREON BCise)[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[6] 6, 17, 72, 78, 193, 233
4Exenatide 10 micrograms
(Synonym: BYDUREON BCISE)		[1] Exenatide (Synonym: BYDUREON BCise)[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6
5Exenatide 5 micrograms
(Synonym: BYDUREON BCISE)		[1] Exenatide (Synonym: BYDUREON BCise)[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6
6Exenatide extended release 2mg (Bydureon)[1] Exenatide (Synonym: BYDUREON BCise)[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6
7Exenatide Pen Injector [Bydureon][1] Exenatide (Synonym: BYDUREON BCise)[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 17
8Experimental: GLP1-RA (exenatide) administration
(Synonym: BYDUREON BCISE)		[1] Exenatide (Synonym: BYDUREON BCise)[1] D04121 (Name: BYDUREON BCISE)[1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 72, 78